Franklin Park, NJ, United States of America

Priyanka Apurva Madia

USPTO Granted Patents = 6 

Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
6 patents (USPTO):

Title: Innovations of Priyanka Apurva Madia

Introduction

Priyanka Apurva Madia is an accomplished inventor based in Franklin Park, NJ (US). She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic proteins and antibodies. With a total of 6 patents to her name, her work has the potential to impact various medical applications.

Latest Patents

Among her latest patents is the development of interleukin-2/interleukin-2 receptor alpha fusion proteins. This patent discloses fusion proteins that comprise a first polypeptide of Interleukin-2 (IL2) and a second polypeptide that includes an extracellular domain of Interleukin-2 Receptor alpha (IL2Rα). Notably, these proteins have at least one fewer glycosylation site compared to their native counterparts. The patent also covers methods of production and therapeutic use of these fusion proteins. Another significant patent involves nucleic acids encoding anti-TREM-1 antibodies. These antibodies specifically bind and inhibit TREM-1 signaling without inducing inflammatory cytokine production in myeloid cells. This innovation has promising therapeutic applications, particularly in treating autoimmune diseases.

Career Highlights

Priyanka is currently employed at Bristol-Myers Squibb Company, where she continues to advance her research and development efforts. Her work at this leading biopharmaceutical company allows her to collaborate with other experts in the field and contribute to groundbreaking medical solutions.

Collaborations

Some of her notable coworkers include Mary Struthers and Jonathan Harry Davis. Their collaborative efforts enhance the innovative environment at Bristol-Myers Squibb Company.

Conclusion

Priyanka Apurva Madia's contributions to biotechnology through her patents and work at Bristol-Myers Squibb Company exemplify her dedication to advancing medical science. Her innovations hold great promise for future therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…